{"entity":{"type":"insider","cik":"0001614875","url":"/insider/0001614875","json_url":"/insider/0001614875.json","name":"Gasmi Mehdi","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":20,"first":"2015-04-08","last":"2020-07-22","span_basis":"filed_date"},"name_variants":[{"name":"Gasmi Mehdi","source":"filing","n_filings":20,"first_seen":"2015-04-08","last_seen":"2020-07-22"}],"transactions":[{"id":2731451,"accession":"0001209191-20-043426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-043426","line_url":"/filing/0001209191-20-043426#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.5956,"price_display":"17.60","price_state":"stated","total_value":87978.0,"total_display":"87,978.00","total_whole":"87,978","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-22","scope":"insider"},{"id":3258121,"accession":"0001209191-20-038635","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038635","line_url":"/filing/0001209191-20-038635#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23605.0,"shares_display":"23,605","price_per_share":25.0632,"price_display":"25.06","price_state":"stated","total_value":591616.836,"total_display":"591,616.84","total_whole":"591,617","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-23","scope":"insider"},{"id":3115149,"accession":"0001209191-20-037769","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-037769","line_url":"/filing/0001209191-20-037769#line-4","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11127.0,"shares_display":"11,127","price_per_share":25.0138,"price_display":"25.01","price_state":"stated","total_value":278328.5526,"total_display":"278,328.55","total_whole":"278,329","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-18","scope":"insider"},{"id":3115140,"accession":"0001209191-20-037769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037769","line_url":"/filing/0001209191-20-037769#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":268.0,"shares_display":"268","price_per_share":25.0101,"price_display":"25.01","price_state":"stated","total_value":6702.7068,"total_display":"6,702.71","total_whole":"6,703","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-18","scope":"insider"},{"id":3313549,"accession":"0001209191-20-037339","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-037339","line_url":"/filing/0001209191-20-037339","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.86268951,"price_display":"21.86","price_state":"stated","total_value":218626.8951,"total_display":"218,626.90","total_whole":"218,627","shares_owned_after":279442.0,"shares_owned_after_display":"279,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-17","scope":"insider","n_lines":4},{"id":3089544,"accession":"0001209191-20-031872","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-031872","line_url":"/filing/0001209191-20-031872#line-4","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3599.0,"shares_display":"3,599","price_per_share":20.0189,"price_display":"20.02","price_state":"stated","total_value":72048.0211,"total_display":"72,048.02","total_whole":"72,048","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-22","scope":"insider"},{"id":3089539,"accession":"0001209191-20-031872","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-031872","line_url":"/filing/0001209191-20-031872#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1401.0,"shares_display":"1,401","price_per_share":20.0071,"price_display":"20.01","price_state":"stated","total_value":28029.9471,"total_display":"28,029.95","total_whole":"28,030","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-22","scope":"insider"},{"id":2286511,"accession":"0001209191-20-031047","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-031047","line_url":"/filing/0001209191-20-031047","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.16661,"price_display":"18.17","price_state":"stated","total_value":90833.05,"total_display":"90,833.05","total_whole":"90,833","shares_owned_after":274742.0,"shares_owned_after_display":"274,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider","n_lines":2},{"id":2286503,"accession":"0001209191-20-031047","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-031047","line_url":"/filing/0001209191-20-031047#line-4","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":20.0267,"price_display":"20.03","price_state":"stated","total_value":500667.5,"total_display":"500,667.50","total_whole":"500,668","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-20","scope":"insider"},{"id":2286498,"accession":"0001209191-20-031047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-031047","line_url":"/filing/0001209191-20-031047#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.2573,"price_display":"16.26","price_state":"stated","total_value":162573.0,"total_display":"162,573.00","total_whole":"162,573","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-20","scope":"insider"},{"id":3087132,"accession":"0001209191-20-011155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-011155","line_url":"/filing/0001209191-20-011155#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.2312,"price_display":"16.23","price_state":"stated","total_value":81156.0,"total_display":"81,156.00","total_whole":"81,156","shares_owned_after":258979.0,"shares_owned_after_display":"258,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider"},{"id":9271187,"accession":"0001209191-20-031045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031045","line_url":"/filing/0001209191-20-031045#line-1","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.069,"price_display":"15.07","price_state":"stated","total_value":150690.0,"total_display":"150,690.00","total_whole":"150,690","shares_owned_after":274442.0,"shares_owned_after_display":"274,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-12","filed_date":"2020-05-20","scope":"insider"},{"id":2367173,"accession":"0001209191-20-009847","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-009847","line_url":"/filing/0001209191-20-009847#line-5","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.069,"price_display":"15.07","price_state":"stated","total_value":150690.0,"total_display":"150,690.00","total_whole":"150,690","shares_owned_after":258979.0,"shares_owned_after_display":"258,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-12","filed_date":"2020-02-14","scope":"insider"},{"id":8791945,"accession":"0001181431-15-008440","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-008440","line_url":"/filing/0001181431-15-008440#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (SVP,Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (SVP,Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP,Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":39.862,"price_display":"39.86","price_state":"stated","total_value":19931.0,"total_display":"19,931.00","total_whole":"19,931","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-17","scope":"insider"},{"id":8810859,"accession":"0001181431-15-008143","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-15-008143","line_url":"/filing/0001181431-15-008143","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":38.6417774,"price_display":"38.64","price_state":"stated","total_value":19320.8887,"total_display":"19,320.89","total_whole":"19,321","shares_owned_after":7265.0,"shares_owned_after_display":"7,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider","n_lines":3},{"id":9269637,"accession":"0001209191-15-050818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-050818","line_url":"/filing/0001209191-15-050818#line-1","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":38.018,"price_display":"38.02","price_state":"stated","total_value":19009.0,"total_display":"19,009.00","total_whole":"19,009","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-28","filed_date":"2015-06-05","scope":"insider"},{"id":8810853,"accession":"0001181431-15-007640","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-007640","line_url":"/filing/0001181431-15-007640#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":38.018,"price_display":"38.02","price_state":"stated","total_value":19009.0,"total_display":"19,009.00","total_whole":"19,009","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-28","filed_date":"2015-05-29","scope":"insider"},{"id":8093555,"accession":"0001209191-15-046179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-046179","line_url":"/filing/0001209191-15-046179#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":38.87,"price_display":"38.87","price_state":"stated","total_value":19435.0,"total_display":"19,435.00","total_whole":"19,435","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-21","filed_date":"2015-05-22","scope":"insider"},{"id":8530945,"accession":"0001181431-15-007004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-007004","line_url":"/filing/0001181431-15-007004#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":35.3125,"price_display":"35.31","price_state":"stated","total_value":17656.25,"total_display":"17,656.25","total_whole":"17,656","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-14","filed_date":"2015-05-15","scope":"insider"},{"id":8847370,"accession":"0001209191-15-040782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-040782","line_url":"/filing/0001209191-15-040782#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":33.2763,"price_display":"33.28","price_state":"stated","total_value":16638.15,"total_display":"16,638.15","total_whole":"16,638","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-07","filed_date":"2015-05-08","scope":"insider"},{"id":8460044,"accession":"0001209191-15-037578","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-037578","line_url":"/filing/0001209191-15-037578#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":35.667,"price_display":"35.67","price_state":"stated","total_value":35667.0,"total_display":"35,667.00","total_whole":"35,667","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-28","filed_date":"2015-04-30","scope":"insider"},{"id":8060277,"accession":"0001140361-15-016257","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-016257","line_url":"/filing/0001140361-15-016257#line-3","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":39.2114,"price_display":"39.21","price_state":"stated","total_value":39211.4,"total_display":"39,211.40","total_whole":"39,211","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-21","filed_date":"2015-04-23","scope":"insider"},{"id":8176842,"accession":"0001140361-15-015524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-015524","line_url":"/filing/0001140361-15-015524#line-2","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":39.448,"price_display":"39.45","price_state":"stated","total_value":39448.0,"total_display":"39,448.00","total_whole":"39,448","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2015-04-15","scope":"insider"},{"id":8401057,"accession":"0001140361-15-014737","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-014737","line_url":"/filing/0001140361-15-014737","is_derivative":false,"issuer_cik":"0001501756","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001501756","owner_cik":"0001614875","owner_name":"Gasmi Mehdi","owner_display_name":"Gasmi Mehdi","owner_url":"/insider/0001614875","role":"Officer (VP, Pharmaceutical Development)","role_mark":"O","role_mark_label":"Officer (VP, Pharmaceutical Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Pharmaceutical Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":38.60274297777778,"price_display":"38.60","price_state":"stated","total_value":347424.6868,"total_display":"347,424.69","total_whole":"347,425","shares_owned_after":292.0,"shares_owned_after_display":"292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-07","filed_date":"2015-04-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Adverum Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Director, Officer (SVP,Pharmaceutical Development)","n_filings":20,"first_seen":"2015-04-08","last_seen":"2020-07-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001614875","retrieved_at":"2026-08-27T14:00:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}